We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines

    Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer with high rates of metastasis and mortality. In vitro studies suggest that...

    Deepika Narayanan, Brooke Bartley, ... Stephen K. Tyring in Archives of Dermatological Research
    Article 01 June 2024
  2. Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target

    Canine mammary gland tumors (MGT) have a poor prognosis in intact female canines, posing a clinical challenge. This study aimed to establish novel...

    Seo-Young Park, Yeong-Bin Baek, ... Sung-Hak Kim in BMC Veterinary Research
    Article Open access 29 May 2024
  3. HAMLET effect on cell death and mitochondrial respiration in colorectal cancer cell lines with KRAS/BRAF mutations

    Purpose

    Treatment of advanced colorectal cancer (CRC) depends on the correct selection of personalized strategies. HAMLET (Human Alpha-lactalbumin...

    Justas Žilinskas, Darius Stukas, ... Algimantas Tamelis in Journal of Cancer Research and Clinical Oncology
    Article Open access 26 April 2023
  4. Auraptene-induced cytotoxic effects in acute myeloid leukemia cell lines

    Acute myeloid leukemia is one of the most commonly identified hematological malignancies with poor prognosis. This research was planned to identify...

    Majid Ghorbani, Mohammad Soukhtanloo, ... Mohammad Hadi Sadeghian in Medical Oncology
    Article 11 July 2023
  5. Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations

    Purpose

    Choroid plexus carcinomas (CPCs) are extremely rare brain tumors and carry a dismal prognosis. Treatment options are limited and there is an...

    Dina Hesham, Jotaro On, ... Manabu Natsumeda in Journal of Neuro-Oncology
    Article 08 January 2024
  6. Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

    Background

    Cell-cycle regulators are mutated in approximately 40% of all cancer types and have already been linked to worse outcomes in non-small cell...

    Francesco Volta, Silvia La Monica, ... Roberta Alfieri in Targeted Oncology
    Article Open access 19 October 2023
  7. Evaluation of chlorophyll-loaded mesoporous silica nanoparticles for photodynamic therapy on cancer cell lines

    Chlorophyll (Chl) is a promising natural photosensitizer (PS) in photodynamic treatment (PDT). Mesoporous silica nanoparticles (MSNs) were chosen to...

    Fadya Adnane, Soliman Mehawed Abdellatif Soliman, ... Heba Mohamed Fahmy in Lasers in Medical Science
    Article Open access 23 January 2024
  8. Altered mitochondrial function in fibroblast cell lines derived from disease carriers of spinal muscular atrophy

    Background

    Spinal muscular atrophy (SMA) is an autosomal recessive childhood-onset neuromuscular disease with a carrier frequency of ~1:50....

    Rachel James, Kiterie M. E. Faller, ... Thomas H. Gillingwater in Communications Medicine
    Article Open access 15 May 2024
  9. The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines

    Alterations in the DNA damage response play a crucial role in radio- and chemoresistance of neoplastic cells. Activation of the Ataxia telangiectasia...

    Julia Schnoell, Carmen Sparr, ... Bernhard J. Jank in Investigational New Drugs
    Article Open access 07 November 2023
  10. Anticancer potential of four triterpenoids against NCI-60 human tumor cell lines

    Background

    The burden of cancer incidences and mortality is rapidly increasing worldwide resulting in an increased demand for new therapies. Secondary...

    Beatrice Njeri Irungu, Mary Nyangi, Fidelis Toloyi Ndombera in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 31 May 2024
  11. Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines

    Purpose

    NKG2A, an inhibitory receptor expressed on NK cells and T cells, leads to immune evasion by binding to HLA-E expressed on cancer cells. Here,...

    Jeongjae Lee, Bhumsuk Keam, ... Dae Seog Heo in Journal of Cancer Research and Clinical Oncology
    Article 22 December 2022
  12. Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines

    Small molecule Bruton’s tyrosine kinase (BTK) inhibitors have been developed for the treatment of various haemato-oncological diseases, and ibrutinib...

    Hana Dostálová, Radek Jorda, ... Vladimír Kryštof in Investigational New Drugs
    Article Open access 13 March 2023
  13. Toxicity evaluation of synthetic glucocorticoids against breast cancer cell lines MDA-MB-231, MCF-7 and human embryonic kidney HEK293

    In this study, we conducted a comprehensive assessment of the cytotoxicity of three glucocorticoids, namely Hydrocortisone, Dexamethasone, and...

    Dhouha Msalbi, Fatma Jellali, ... Sami Aifa in Medical Oncology
    Article 29 September 2023
  14. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers

    Background

    In the treatment of oral squamous cell carcinoma (OSCC), radiation resistance remains an important obstacle to patient outcomes. Progress...

    Junhong Huang, Qingzhe Meng, ... Jianhua Wei in Clinical and Translational Oncology
    Article 07 April 2023
  15. Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis

    Background

    Among reproductive cancers, ovarian cancer leads to the highest female mortality rate. Fisetin, a natural flavonoid, exerts pharmacological...

    Yaxian Liu, Hongwen Cao, ... Shuhai Lan in Journal of Ovarian Research
    Article Open access 10 May 2022
  16. Anticancer properties of red beetroot hydro-alcoholic extract and its main constituent; betanin on colorectal cancer cell lines

    Colorectal cancer (CRC) is the third most common type of cancer worldwide. Red beetroot ( Beta vulgaris ) contains Betanin as its major betacyanin,...

    Amir Saber, Nasim Abedimanesh, ... Shima Moradi in BMC Complementary Medicine and Therapies
    Article Open access 18 July 2023
  17. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines

    Background

    Gastrointestinal cancer (GIC) ranks as the highest cause of cancer-related deaths globally. GIC patients are often diagnosed at advanced...

    Sutthiwan Janthamala, Bundit Promraksa, ... Anchalee Techasen in BMC Complementary Medicine and Therapies
    Article Open access 30 April 2024
  18. Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines

    Objectives

    c-Met, a receptor tyrosine kinase, is involved in the growth, invasion and metastasis of a variety of cancers. In a set of cell lines from...

    Aisha A. H. Al-Jamaei, Jan G. A. M. de Visscher, ... Marco N. Helder in Journal of Cancer Research and Clinical Oncology
    Article Open access 02 September 2022
  19. Cytotoxicity of poly-guanidine in medulloblastoma cell lines

    Medulloblastoma (MB) is the most common pediatric brain tumor. The therapy frequently causes serious side effects, and new selective therapies are...

    Gabriel Gallo-Oller, Teresita Díaz de Ståhl, ... Marcela Márquez-Méndez in Investigational New Drugs
    Article Open access 09 August 2023
  20. Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition

    Purpose

    Circulating tumour cells (CTCs) are a rare cell subpopulation regulated by the tumour microenvironment. In hypoxic conditions, CTCs are able...

    Joanna Kapeleris, Juliana Müller Bark, ... Chamindie Punyadeera in Journal of Cancer Research and Clinical Oncology
    Article Open access 06 August 2022
Did you find what you were looking for? Share feedback.